Collegium Pharmaceutical (COLL) PT Lowered to $26 at Needham & Company

Go back to Collegium Pharmaceutical (COLL) PT Lowered to $26 at Needham & Company

Collegium Pharmaceutical (COLL) PT Lowered to $27 at Truist Securities

November 5, 2021 5:07 AM EDT

Truist Securities analyst Gregg Gilbert lowered the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $27.00 (from $28.00) while maintaining a Buy rating.... More